Brain zapping after magic mushrooms may lock in Life-Changing insights
NCT ID NCT05866471
First seen Jun 26, 2026 · Last updated Jul 30, 2026 · Updated 3 times
Summary
This study explores whether combining a single dose of psilocybin (the active ingredient in magic mushrooms) with a gentle ear stimulation device can help people remember the insights they gain during the psychedelic experience for longer. Researchers will enroll 108 healthy adults with mild emotional distress and use brain scans and memory questionnaires to measure effects. The goal is to understand how to enhance the lasting benefits of psychedelic experiences.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- psilocybin
- What this could lead to
- If it works, this could point toward a way to make insights from psychedelic experiences last longer, potentially improving mental well-being.
- What could go wrong
- This is an early Phase 1 study in healthy volunteers, so it's not testing a treatment for any disease. The effects may be small or not last, and psilocybin can cause temporary psychological distress.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Wisconsin - Madison
RECRUITINGMadison, Wisconsin, 53715, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test